Aspira Pathlab & Diagnostics Share Price

    66.54
    +1.40 (2.15%)
    ASPIRA • 14 Oct, 2025 | 03:29 PM
    Buy

    1Y Annualised Return

    102.01%

    3Y Annualised Return

    12.96%

    The current prices are delayed, login or Open Demat Account for live prices.

    Aspira Pathlab & Diagnostics Stock Performance

    1W Return1.73
    1Y Return45.86
    Today's Low65.71
    Prev. Close65.14
    Mkt Cap (Cr.)68.49
    1M Return7.34
    3Y Return51.23
    52-Week High106.78
    Open68.39
    PE Ratio26.72
    6M Return5.77
    Today's High68.39
    52-Week Low44.03
    Face Value10

    Aspira Pathlab & Diagnostics Company background

    Founded in: 1973
    Managing director: Pankaj Jashwant Shah
    Aspira Pathlab Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with PanIndia presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services.Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.During the year, the Company commenced its business activities of diagnostic center pathology from November 2016 onwards by acquiring running business activities of Ankur Pathology Laboratory. Aspira is focused on establishing itself as a strong regional player before scaling up its operations. Although, it follow an asset light model, other costs are significantly high. Most of these cost is front ended and the payback period is high. It is therefore working on building the right systems and optimize the cost. It is adopting new technologies that improve customer experience. Some of these are use of Chatbot, improving website, implementing patient engagement platform, Customer Service, etc. Also concentrating more on HLM, trying to expand area by targeting newly setup hospitals and laboratory and trying to achieve more technology and advancement.

    Aspira Pathlab & Diagnostics Financial Highlights


    For the full year FY2025–2026, revenue reached ₹22.39 crore and profit touched at ₹2.07 crore.

    Aspira Pathlab & Diagnostics Share Price Today


    As of 15 Oct 2025, Aspira Pathlab & Diagnostics share price is ₹66.5. The stock opened at ₹68.4 and had closed at ₹65.1 the previous day. During today’s trading session, Aspira Pathlab & Diagnostics share price moved between ₹65.71 and ₹68.39, with an average price for the day of ₹67.05. Over the last 52 weeks, the stock has recorded a low of ₹44.03 and a high of ₹106.78. In terms of performance, Aspira Pathlab & Diagnostics share price has increased by 5.8% over the past six months and has increased by 102.01% over the last year.
    Read More
    Aspira Pathlab & Diagnostics SIP Return Calculator

    Over the past

    1 year
    3 years
    Total Investment of ₹1,80,000
    Monthly SIP of 5,000 would have become 2,20,942 in 3 years with a gain of 40,942 (+22.75%)
    View details of Market Depth

    Aspira Pathlab & Diagnostics Fundamental

    Market Cap (in crs)

    68.49

    Face Value

    10

    Turnover (in lacs)

    14.81

    Key Metrics

    Qtr Change %
    37.68% Fall from 52W High
    24.4
    Dividend yield 1yr %
    0

    Aspira Pathlab & Diagnostics Key Financials

    View more
    Loading chart...
    Loading chart...
    Loading chart...
    Loading chart...
    Aspira Pathlab & Diagnostics Quarterly Revenue
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    5.25 Cr
    5.78 Cr
    5.41 Cr
    6.18 Cr
    4.64 Cr
    Aspira Pathlab & Diagnostics Yearly Revenue
    Mar 2025
    22.39 Cr
    Aspira Pathlab & Diagnostics Quarterly Net Profit/Loss
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    0.47 Cr
    0.72 Cr
    0.31 Cr
    0.99 Cr
    -0.02 Cr
    Aspira Pathlab & Diagnostics Yearly Net Profit/Loss
    Mar 2025
    2.07 Cr

    Aspira Pathlab & Diagnostics Shareholding Pattern

    Promoter
    18.4%
    Public
    81.6%
    Promoter
    18.4%
    Public
    81.6%
    Promoter
    18.6%
    Public
    81.5%
    Promoter
    18.6%
    Public
    81.5%
    Promoter
    18.7%
    Public
    81.3%
    Promoter
    18.7%
    Public
    81.3%

    Aspira Pathlab & Diagnostics Technical Analysis

    Moving Averages Analysis
    66.54
    Current Price
    Bullish Moving Averages
    16
    Bearish Moving Averages
    0
    5Day EMA
    64.60
    10Day EMA
    64.40
    12Day EMA
    64.40
    20Day EMA
    64.20
    26Day EMA
    64.00
    50Day EMA
    63.20
    100Day EMA
    62.70
    200Day EMA
    61.20
    5Day SMA
    63.00
    10Day SMA
    65.40
    20Day SMA
    64.30
    30Day SMA
    63.90
    50Day SMA
    63.70
    100Day SMA
    60.20
    150Day SMA
    64.30
    200Day SMA
    65.80
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    19194 Rs
    22260 Rs
    Week Rs
    19347 Rs
    24628 Rs
    Month Rs
    10834 Rs
    13955 Rs
    66.88
    Pivot
    Resistance
    First Resistance
    68.05
    Second Resistance
    69.56
    Third Resistance
    70.73
    Support
    First Support
    65.37
    Second support
    64.20
    Third Support
    62.69
    Relative Strength Index
    54.61
    Money Flow Index
    17.56
    MACD
    0.40
    MACD Signal
    0.46
    Average True Range
    3.52
    Average Directional Index
    11.84
    Rate of Change (21)
    7.34
    Rate of Change (125)
    5.77

    Aspira Pathlab & Diagnostics Latest News

    13 OCT 2025 | Monday

    Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Open Offer - Updates

    13 OCT 2025 | Monday

    Aspira Pathlab & Diagnostics Ltd - 540788 - Draft Letter of Offer

    07 OCT 2025 | Tuesday

    Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    View More

    Aspira Pathlab & Diagnostics Share Price FAQs

    You can easily buy Aspira Pathlab & Diagnostics shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Aspira Pathlab & Diagnostics share price is ₹106.78 and ₹44.03 as of 14/10/2025.

    Please be aware that Aspira Pathlab & Diagnostics stock prices are subject to continuous fluctuations due to various factors.

    Invest in Aspira Pathlab & Diagnostics
    +91 -

    Popular Stocks
    53.95
    -0.40 (-0.74%)
    124.52
    -0.98 (-0.78%)
    395.45
    -4.55 (-1.14%)
    2,517.00
    -10.40 (-0.41%)
    154.52
    +4.45 (+2.97%)
    333.05
    -6.10 (-1.80%)
    170.51
    -2.52 (-1.46%)
    347.75
    -0.60 (-0.17%)
    402.40
    -7.00 (-1.71%)
    391.55
    +0.40 (+0.10%)
    Top Gainers
    1,161.50
    +18.20 (+1.59%)
    248.42
    +3.29 (+1.34%)
    1,468.00
    +17.10 (+1.18%)
    7,759.00
    +88.00 (+1.15%)
    287.50
    +1.35 (+0.47%)
    Top Losers
    1,237.30
    -25.10 (-1.99%)
    402.40
    -7.00 (-1.71%)
    1,019.15
    -17.60 (-1.70%)
    2,960.30
    -46.90 (-1.56%)
    336.65
    -5.05 (-1.48%)
    Invest in Aspira Pathlab & Diagnostics
    +91 -